Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become a cornerstone medication for weight loss management, with clinical trials showing average weight reductions of 15-22% over 68 weeks. The medication is available through multiple delivery methods, each with distinct advantages for patient compliance and effectiveness. Understanding your options helps you select the approach that best fits your lifestyle and health goals.

How Semaglutide Injections Deliver Weight Loss Results

Semaglutide injections work by mimicking glucagon-like peptide-1, a natural hormone that regulates appetite and blood sugar. When administered subcutaneously once weekly, the medication activates GLP-1 receptors in the brain's appetite control centers, reducing hunger signals and increasing feelings of fullness. This mechanism allows most patients to naturally consume fewer calories without severe dietary restrictions.

The injectable form delivers medication directly into subcutaneous tissue beneath the skin, where it absorbs gradually over seven days. This sustained-release pattern maintains consistent blood levels, avoiding the peaks and valleys that can trigger side effects or reduced effectiveness. Weekly dosing also simplifies the treatment schedule compared to daily oral medications, improving long-term adherence rates.

Compounded Semaglutide Versus Brand-Name Injectable Options

Brand-name semaglutide injectables like Wegovy carry significant costs, often exceeding $900 to $1,300 monthly without insurance coverage. PlexusDx sources compounded semaglutide injections from licensed 503A compounding pharmacies, meeting the same FDA manufacturing standards while reducing expenses to $149 per month. Both formulations contain identical active ingredients and work through the same biological pathways when properly compounded and stored.

Compounded medications allow for personalized dosing flexibility that brand-name products sometimes restrict. Patients can adjust their weekly dose more gradually under medical supervision, reducing nausea and gastrointestinal side effects during the initial treatment phase. PlexusDx serves all 50 states without requiring insurance, and treatment costs are eligible for HSA and FSA accounts, making consistent access more achievable.

Injectable Versus Oral Semaglutide: Which Delivery Method Works Better

Semaglutide injections demonstrate superior bioavailability compared to oral formulations because they bypass digestive breakdown. Injectable medication reaches systemic circulation more efficiently, requiring lower total doses to achieve the same weight loss results. Clinical data shows injections produce more predictable weight reduction rates, particularly in patients with slower metabolism or varying stomach acid levels.

Oral semaglutide requires taking a tablet daily on an empty stomach with specific water intake instructions, which can reduce real-world adherence. Weekly injections eliminate daily pill-taking burden and provide patients with a clear, scheduled routine that many find easier to maintain long-term. For individuals struggling with medication compliance or those who prefer fewer daily tasks, injections offer a practical advantage.

Personalized Treatment with Semaglutide and Genetic Insights

Individual responses to semaglutide vary based on genetic variations affecting appetite regulation and weight metabolism. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 49 peptides to identify how your body responds to GLP-1 medications. Genetic markers like GLP1R rs6923761 and GIPR rs1800437 influence receptor sensitivity, helping predict whether standard or higher doses will optimize your results.

The FTO rs9939609 variant affects appetite signaling and overall weight regulation capacity, while MC4R rs17782313 impacts metabolic rate and satiety response. Understanding these genetic predispositions allows PlexusDx providers to recommend the most effective starting dose and anticipate your likely treatment timeline. This precision approach reduces trial-and-error dosing and improves the likelihood of sustained weight loss maintenance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy a shot, and how often do you inject it?

Yes, Wegovy is a subcutaneous injection administered once weekly by patients at home. PlexusDx compounded semaglutide injections follow the same weekly dosing schedule and work identically to brand-name Wegovy, costing significantly less at $149 per month.

What percentage of weight loss can I expect from semaglutide injections?

Clinical trials show average weight loss of 15-22% of body weight over 68 weeks with consistent semaglutide use. Individual results vary based on genetics, diet, activity level, and dose titration; PlexusDx's Precision Peptide Genetic Test can help predict your likely response.

How much does semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers, with no dose-dependent price increases. Treatment is available in all 50 states without insurance, and costs are HSA and FSA eligible.

Are compounded semaglutide injections safe and effective?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies that meet strict FDA manufacturing standards. Compounded formulations contain identical active ingredients to brand-name products and produce equivalent weight loss results when properly prepared.

How can genetic testing improve my semaglutide treatment outcomes?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies variations in GLP1R, GIPR, FTO, and MC4R genes that predict your medication response. This genetic insight helps providers select optimal starting doses and identify whether additional peptide compounds like tirzepatide may enhance your results.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves